Follow-The-Filings

Security · featured owners

DMAC Diamedica Therapeutics Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.7%
  • $24M
  • 1 add

DMAC (Diamedica Therapeutics Inc.) is held in 1 featured 13F book as of 2026 Q2. Leon Cooperman - Omega Advisors is the largest tracked holder by portfolio weight (0.68%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.7% (Leon Cooperman - Omega Advisors) · not free-float ownership

  1. Leon Cooperman add 0.68%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Leon Cooperman - Omega Advisors 2026 Q2 0.68% Add +70.8% 3,450,000 $24M history

1 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$19.38M -$24.44M -$32.77M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $53.68M $44.61M $60.63M
Total non-current assets $0.485M $1.74M $0.742M
Total assets $54.16M $46.34M $61.37M
Total current liabilities $2.79M $5.39M $5.13M
Total non-current liabilities $317,000 $237,000 $128,000
Total equity $51.06M $40.72M $56.11M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$18.73M -$22.08M -$29.06M
Cash from investing -$18.3M $8.56M -$2.19M
Cash from financing $36.84M $11.99M $43.88M
Net change in cash -$0.185M -$1.52M $12.62M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders